Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · BILL · 117th Congress · S. 3799 (Introduced in Senate) — To prepare for, and respond to, existing viruses, emerging new threats, and pandemics. · Sec. 1

Sec. 1. Short title; table of contents

733 words·~3 min read·/bill/117/s/3799/is/section-1·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the or the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act . PREVENT Pandemics Act The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. TITLE I—Strengthening Federal and State preparedness Subtitle A—Federal leadership and accountability Sec. 101. Comprehensive review of the COVID–19 response. Sec. 102. Appointment and authority of the Director of the Centers for Disease Control and Prevention.
Sec. 103. Additional provisions related to the Centers for Disease Control and Prevention. Sec. 104. Public health and medical preparedness and response coordination. Sec. 105. Strengthening public health communication. Sec. 106. Office of Pandemic Preparedness and Response Policy. Subtitle B—State and local readiness Sec. 111. Improving State and local public health security. Sec. 112. Supporting access to mental health and substance use disorder services during public health emergencies.
Sec. 113. Trauma care reauthorization. Sec. 114. Assessment of containment and mitigation of infectious diseases. TITLE II—Improving public health preparedness and response capacity Subtitle A—Addressing disparities and improving public health emergency responses Sec. 201. Addressing social determinants of health and improving health outcomes. Sec. 202. National Academies of Sciences, Engineering, and Medicine report. Subtitle B—Improving public health data Sec. 211. Modernizing biosurveillance capabilities and infectious disease data collection.
Sec. 212. Genomic sequencing, analytics, and public health surveillance of pathogens. Sec. 213. Supporting public health data availability and access. Sec. 214. Epidemic forecasting and outbreak analytics. Sec. 215. Report on CDC data portal. Sec. 216. Public health data transparency. Subtitle C—Revitalizing the public health workforce Sec. 221. Improving recruitment and retention of the frontline public health workforce. Sec. 222. Awards to support community health workers and community health.
Sec. 223. Improving public health emergency response capacity. Sec. 224. Extension of authorities to support health professional volunteers at community health centers. Sec. 225. Increasing educational opportunities for allied health professions. Sec. 226. Public Health Service Corps annual and sick leave. Subtitle D—Improving public health responses Sec. 231. Centers for public health preparedness and response. Sec. 232. Vaccine distribution plans. Sec. 233. Coordination and collaboration regarding blood supply.
TITLE III—Accelerating research and countermeasure discovery Subtitle A—Fostering research and development and improving coordination Sec. 301. Research and activities related to long-term health effects of SARS–CoV–2 infection. Sec. 302. Research centers for pathogens of pandemic concern. Sec. 303. Improving medical countermeasure research coordination. Sec. 304. Accessing specimen samples and diagnostic tests. Subtitle B—Improving biosafety and biosecurity Sec. 311. Improving control and oversight of select biological agents and toxins.
Sec. 312. Strategy for Federal high-containment laboratories. Sec. 313. National Science Advisory Board for Biosecurity. Sec. 314. Research to improve biosafety. Sec. 315. Federally-funded research with enhanced pathogens of pandemic potential. Subtitle C—Preventing undue foreign influence in biomedical research Sec. 321. Foreign talent programs. Sec. 322. Securing identifiable, sensitive information. Sec. 323. Duties of the Director. Sec. 324. Protecting America’s biomedical research enterprise.
Sec. 325. GAO Study. Sec. 326. Report on progress to address undue foreign influence. TITLE IV—Modernizing and strengthening the supply chain for vital medical products Sec. 401. Warm base manufacturing capacity for medical countermeasures. Sec. 402. Supply chain considerations for the Strategic National Stockpile. Sec. 403. Strategic National Stockpile equipment maintenance. Sec. 404. Improving transparency and predictability of processes of the Strategic National Stockpile.
Sec. 405. Improving supply chain flexibility for the Strategic National Stockpile. Sec. 406. Reimbursement for certain supplies. Sec. 407. Action reporting on stockpile depletion. Sec. 408. Provision of medical countermeasures to Indian programs and facilities. Sec. 409. Grants for State strategic stockpiles. TITLE V—Enhancing development and combating shortages of medical products Subtitle A—Development and review Sec. 501. Advancing qualified infectious disease product innovation.
Sec. 502. Modernizing clinical trials. Sec. 503. Accelerating countermeasure development and review. Sec. 504. Third party test evaluation during emergencies. Sec. 505. Facilitating the use of real world evidence. Sec. 506. Platform technologies. Sec. 507. Increasing EUA decision transparency. Sec. 508. Improving FDA guidance and communication. Sec. 509. GAO study and report on hiring challenges at FDA. Subtitle B—Mitigating shortages Sec. 511. Ensuring registration of foreign drug and device manufacturers.
Sec. 512. Extending expiration dates for certain drugs. Sec. 513. Unannounced foreign facility inspections pilot program. Sec. 514. Combating counterfeit devices. Sec. 515. Strengthening medical device supply chains. Sec. 516. Preventing medical device shortages. Sec. 517. Remote records assessments for medical devices. Sec. 518. Advanced manufacturing technologies designation pilot program. Sec. 519. Technical corrections.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.